A carregar...
An Update of Prophylactic Human Papillomavirus L1 Virus-Like Particle Vaccine Clinical Trial Results
This review focuses on recent publications of clinical trials of two prophylactic Human Papillomavirus (HPV) vaccines: Gardasil® (Merck & Co., Whitehouse Station, NJ USA), a quadrivalent vaccine containing L1 virus-like particles (VLPs) of types −6, 11, 16, and 18, and Cervarix® (GlaxoSmithKline...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2631230/ https://ncbi.nlm.nih.gov/pubmed/18847557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.06.002 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|